GURUFOCUS.COM » STOCK LIST » Technology » Software » Imperva Inc (NAS:IMPV) » Definitions » ROE %

Imperva (Imperva) ROE % : 1.26% (As of Sep. 2018)


View and export this data going back to 2011. Start your Free Trial

What is Imperva ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Imperva's annualized net income for the quarter that ended in Sep. 2018 was $4.2 Mil. Imperva's average Total Stockholders Equity over the quarter that ended in Sep. 2018 was $335.0 Mil. Therefore, Imperva's annualized ROE % for the quarter that ended in Sep. 2018 was 1.26%.

The historical rank and industry rank for Imperva's ROE % or its related term are showing as below:

IMPV's ROE % is not ranked *
in the Software industry.
Industry Median: 3.17
* Ranked among companies with meaningful ROE % only.

Imperva ROE % Historical Data

The historical data trend for Imperva's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Imperva ROE % Chart

Imperva Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
ROE %
Get a 7-Day Free Trial Premium Member Only -28.91 -63.37 -28.97 -29.77 8.36

Imperva Quarterly Data
Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.51 4.75 -11.98 -27.67 1.26

Competitive Comparison of Imperva's ROE %

For the Software - Application subindustry, Imperva's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Imperva's ROE % Distribution in the Software Industry

For the Software industry and Technology sector, Imperva's ROE % distribution charts can be found below:

* The bar in red indicates where Imperva's ROE % falls into.



Imperva ROE % Calculation

Imperva's annualized ROE % for the fiscal year that ended in Dec. 2017 is calculated as

ROE %=Net Income (A: Dec. 2017 )/( (Total Stockholders Equity (A: Dec. 2016 )+Total Stockholders Equity (A: Dec. 2017 ))/ count )
=22.869/( (231.963+315.117)/ 2 )
=22.869/273.54
=8.36 %

Imperva's annualized ROE % for the quarter that ended in Sep. 2018 is calculated as

ROE %=Net Income (Q: Sep. 2018 )/( (Total Stockholders Equity (Q: Jun. 2018 )+Total Stockholders Equity (Q: Sep. 2018 ))/ count )
=4.232/( (328.435+341.619)/ 2 )
=4.232/335.027
=1.26 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Sep. 2018) net income data. ROE % is displayed in the 30-year financial page.


Imperva  (NAS:IMPV) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Sep. 2018 )
=Net Income/Total Stockholders Equity
=4.232/335.027
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(4.232 / 366.532)*(366.532 / 590.2155)*(590.2155 / 335.027)
=Net Margin %*Asset Turnover*Equity Multiplier
=1.15 %*0.621*1.7617
=ROA %*Equity Multiplier
=0.71 %*1.7617
=1.26 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Sep. 2018 )
=Net Income/Total Stockholders Equity
=4.232/335.027
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (4.232 / 6) * (6 / 1.864) * (1.864 / 366.532) * (366.532 / 590.2155) * (590.2155 / 335.027)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.7053 * 3.2189 * 0.51 % * 0.621 * 1.7617
=1.26 %

Note: The net income data used here is four times the quarterly (Sep. 2018) net income data. The Revenue data used here is four times the quarterly (Sep. 2018) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Imperva ROE % Related Terms

Thank you for viewing the detailed overview of Imperva's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Imperva (Imperva) Business Description

Traded in Other Exchanges
N/A
Address
Imperva provides application and data cybersecurity products for enterprises and governments. The company was founded in 2002 and went public in 2011. Imperva reports in two operating segments (products and services) across three geographies (Americas; Europe, Middle East, and Africa; and Asia-Pacific).
Executives
James R Tolonen director
Randall N Spratt director C/O MCKESSON CORPORATION, ONE POST STREET, 33RD FLOOR, SAN FRANCISCO CA 94104
Allan R Tessler director C/O EPOCH HOLDING CORPORATION, 640 FIFTH AVENUE, NEW YORK, NY 10019
Albert A Pimentel director CO GLU MOBILE INC, 1800 GATEWAY DRIVE, SAN MATEO CA 94404
Tram T Phi officer: Chief Legal Officer C/O DOCUSIGN, INC., 221 MAIN STREET, SUITE 1550, SAN FRANCISCO CA 94105
Christopher Hylen director, officer: President and CEO 700 LOCUST STREET, 4TH FLOOR, DUBUQUE IA 52001
Geraldine Elliott director 1194 N. MATHILDA AVE., SUNNYVALE CA 94089
Anthony J Bettencourt director C/O IMPERVA, INC. 3400 BRIDGE PARKWAY REDWOOD SHORES CA 94065
Charles H Giancarlo director 170 WEST TASMAN DRIVE, SAN JOSE X1 95134
Shlomo Kramer 10 percent owner
Ranzetta Theresia Gouw director 428 UNIVERSITY AVE, PALO ALTO CA 94301
Frank Slootman director 106 EAST BABCOCK STREET, SUITE 3A, BOZEMAN MT 59715
Gregory S. Clark director EMULEX CORPORATION, 3333 SUSAN STREET, COSTA MESA CA 92626
Steven M Krausz director 2735 SAND HILL ROAD, MENLO PARK CA 94025
David N Strohm director EMC CORPORATION, 176 SOUTH STREET, HOPKINTON MA 01748